Holy Cross 9th Annual Winter Oncology Symposium

https://www.hconcologysymposium.com/

 

Holy Cross 9th Annual Winter Oncology Symposium
Avatar

Update on Targeted and Immunotherapy in Ovarian Cancer: Frontline/Second-Line PARPi Maintenance, TMB, VEGF, Hormone Therapy

By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Rebecca Stone
March 20, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:03
Novartis Oncology

CDK4/6 Inhibitor Option for HR+/HER2- mBC: Are All CDK4/6 Inhibitors…

Feat. D. Slamon

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi
Gyn Cancers
19:23
Holy Cross 9th Annual Winter Oncology Symposium

Genetic Testing in Breast and Ovarian Cancer: BRCA1/2 and PARP Inhib…

Feat. D. Guaqueta
25:08
Holy Cross 9th Annual Winter Oncology Symposium

Update on Targeted and Immunotherapy in Ovarian Cancer: Frontline/Se…

Feat. R. Stone
26:08
Holy Cross 9th Annual Winter Oncology Symposium

Multidisciplinary Management of Uterine Cancers: From Types and Muta…

Feat. J. Gates
06:24
Holy Cross 9th Annual Winter Oncology Symposium

Panel Discussion: Maintenance in Ovarian Cancer

Feat. E. Segota